GLYXAMBI

药品简介

Originator: GLYXAMBI by BOEHRINGER INGELHEIM · Manufacturer: Boehringer Ingelheim Pharma. Indication & Dosage: GLYXAMBI (EMPAGLIFLOZIN + LINAGLIPTIN) is a prescription medicine used to treat proper diet and exercise programs to control high blood sugar in people with type 2 diabetes. EMPAGLIFLOZIN + LINAGLIPTIN also works for controlling blood sugar and helps prevent sexual function, kidney damage, blindness, nerve problems, and loss of limbs. EMPAGLIFLOZIN + LINAGLIPTIN also lessen your risk of a heart attack or stroke. GLYXAMBI manufactured by BOEHRINGER INGELHEIM Pharma Ltd. In Germany. EMPAGLIFLOZIN + LINAGLIPTIN has to take orally once a day with or without food. Side Effects: The most common side effects of EMPAGLIFLOZIN + LINAGLIPTIN are: Frequent urination , dizziness , or lightheadedness . The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。